Dialister pneumosintes, originally isolated from the nasopharyngeal secretions of patients during the influenza epidemics of 1918 through 1921, was initially considered a potential causative agent of influenza. However, subsequent research invalidated this hypothesis.
Instead, Dialister pneumosintes is primarily associated with dental and periodontal infections, notably gingivitis and periodontitis. Its presence has been identified in a substantial proportion, up to 83%, of subgingival plaque samples from individuals with periodontal diseases. Additionally, it has been detected in dental root canal infections.
This bacterium is not confined to oral infections alone; it can also lead to sinus infections, particularly in individuals with chronic sinusitis or nasal polyps. Cases involving Dialister pneumosintes have been reported in sinus aspirates or biopsies.
On rare occasions, D. pneumosintes can trigger severe systemic infections, including pneumonia, sepsis, and brain abscesses. These systemic infections are infrequent and typically affect immunocompromised or debilitated patients.
Only a few documented cases of these infections exist in the medical literature, with a high mortality rate ranging from 25% to 100%. The prevalence and incidence of D. pneumosintes infections remain largely unknown due to unreliable surveillance or diagnostic methods.
Classification and Structure:
Kingdom: Bacteria
Phylum: Bacillota
Class: Negativicutes
Order: Selenomonadales
Family: Veillonellaceae
Genus: Dialister
Species: D. pneumosintes
Dialister pneumosintes is a nonfermentative bacterium. It is an anaerobic organism, meaning it thrives in environments without oxygen. This bacterium is classified as gram-negative. The size of cells typically ranges from 0.5 to 0.8 μm in width and 1.5 to 3.0 μm in length.
These cells are commonly arranged in pairs or short chains. They may exhibit either tapered or blunt ends. Dialister pneumosintes cells have a thin peptidoglycan layer and an outer membrane. However, they lack a capsule and flagella.
Dialister pneumosintes have the potential to produce enzymes that can degrade host tissues and disrupt the host immune system. Specifically, it may secrete proteases capable of breaking down collagen and elastin fibers within the periodontal ligament, ultimately destroying periodontal tissues.
Notably, ATCC 33048 and CCUG 21025 strains are representative examples of D. pneumosintes. These enzymatic activities can contribute to the bacterium’s pathogenicity within the oral cavity.
Dialister pneumosintes, a member of the normal oral flora in some individuals, can transition to a pathogenic state under specific conditions. Poor oral hygiene, trauma, surgical procedures, or immunosuppression can contribute to its pathogenicity. In such situations, this bacterium is capable of causing inflammation and infection of the gums and teeth.
It achieves this by producing toxins, enzymes, or biofilms that damage oral tissues or, in some cases, enable evasion of the host immune system. D. pneumosintes can enter the bloodstream through damaged oral mucosa or dental procedures.
From there, it can disseminate to other organs and tissues throughout the body, leading to potentially severe consequences such as bacteremia, sepsis, pneumonia, meningitis, or brain abscess. This ability to spread and establish infections at diverse sites underscores the gravity of D. pneumosintes-related illnesses.
Crucially, D. pneumosintes can also employ various strategies to suppress or evade the host immune system. It accomplishes this by producing a protective capsule, forming biofilms, or releasing immunomodulatory factors. These mechanisms shield the bacterium from host immune recognition or elimination, enabling its persistence and proliferation within the host.
Human host defenses against Dialister pneumosintes involve a complex interplay of various immune components, including saliva and salivary defense proteins. Saliva, produced by minor & major salivary glands, is a dynamic body fluid that influences the oral environment. It contains a diverse mixture of molecules, resulting in “mixed saliva,” which is crucial in maintaining oral health.
One significant role of saliva is in acquired pellicle formation on tooth surfaces. This thin layer of salivary proteins, with calcium hydroxide binding properties, helps maintain the balance of mineralization on teeth and acts as a defense against bacterial adhesion and colonization, which can lead to dental issues like caries and periodontal inflammation.
Saliva also contributes to the physico-chemical and immune defense of oral and upper gastrointestinal mucosal surfaces. It contains numerous defense proteins, including salivary immunoglobulins and antimicrobial peptides (host defense peptides or HDPs). These molecules are critical components of innate and acquired immunity, exerting direct antimicrobial actions and agglutinating or excluding microbes from mucosal surfaces.
The primary classes of salivary antibodies include IgA and IgM, with secretory IgA (sIgA) being a predominant form in saliva. The secretory components (SC) of a polymeric immunoglobulin receptor (pIgR) play a crucial role in the secretion of sIgA. Free SCs in saliva have innate defense functions, such as inhibiting bacterial adhesion and neutralizing bacterial toxins.
Host defense peptides, including defensins, cathelicidins, and histatins, are also in saliva. These peptides exhibit broad-spectrum antimicrobial activities and can effectively combat pathogenic microorganisms. They contribute to the innate immune reactions against microbial invasion in the oral cavity and airway.
Salivary defense proteins form a network of molecular defenses in the oral cavity. Multiple proteins can act together to create a “multi-hit” approach, enhancing the elimination of pathogens. These defense networks are responsible for microbial agglutination, lysis of microbial membranes, antifungal and antiviral properties, and immune regulation.
Dialister pneumosintes infections can manifest in various clinical scenarios:
Dental or Periodontal Infections: D. pneumosintes can lead to gingivitis or periodontitis, involving inflammation and infection of the gums and teeth. Typical symptoms encompass redness, swelling, bleeding, pain, and persistent bad breath.
Sinus Infections: This bacterium can cause sinusitis, characterized by inflammation and infection of the sinuses. Symptoms often include nasal congestion, nasal discharge, headache, facial pain, and sometimes fever.
Lung Infections: D. pneumosintes has the potential to induce pneumonia, an inflammatory and infectious condition affecting the lungs. Symptoms may encompass cough, chest pain, shortness of breath, and fever. In prolonged cases, the disease can lead to sepsis, a life-threatening condition where the pathogen spreads into the bloodstream, possibly leading to organ failure.
Brain Infections: One of the more severe consequences can be the development of brain abscesses. These are localized collections of pus within brain tissue and can manifest with symptoms like severe headaches, nausea, vomiting, confusion, seizures, and even paralysis. Timely treatment is crucial as brain abscesses can be fatal if left untreated.
Culture test: To diagnose Dialister pneumosintes, a culture test can be conducted using selective media designed explicitly for anaerobic bacteria. One such medium is CDC Anaerobe Blood Agar supplemented with hemin and menadione.
When cultured under strict anaerobic conditions, D. pneumosintes typically forms small, round, convex, and translucent colonies with a characteristic grayish color. Microscopic examination may reveal gram-negative rods, typically arranged in pairs or short chains.
Molecular Methods: Dialister pneumosintes can be detected using molecular techniques effectively. These include 16S rRNA gene sequencing, polymerase chain reaction, or fluorescence in situ
hybridization (FISH). These molecular methods offer advantages over traditional culture-based approaches as they tend to be more sensitive and specific, providing faster and more accurate results. However, it’s important to note that the availability and standardization of these methods may vary among clinical laboratories.
Dialister pneumosintes, originally isolated from the nasopharyngeal secretions of patients during the influenza epidemics of 1918 through 1921, was initially considered a potential causative agent of influenza. However, subsequent research invalidated this hypothesis.
Instead, Dialister pneumosintes is primarily associated with dental and periodontal infections, notably gingivitis and periodontitis. Its presence has been identified in a substantial proportion, up to 83%, of subgingival plaque samples from individuals with periodontal diseases. Additionally, it has been detected in dental root canal infections.
This bacterium is not confined to oral infections alone; it can also lead to sinus infections, particularly in individuals with chronic sinusitis or nasal polyps. Cases involving Dialister pneumosintes have been reported in sinus aspirates or biopsies.
On rare occasions, D. pneumosintes can trigger severe systemic infections, including pneumonia, sepsis, and brain abscesses. These systemic infections are infrequent and typically affect immunocompromised or debilitated patients.
Only a few documented cases of these infections exist in the medical literature, with a high mortality rate ranging from 25% to 100%. The prevalence and incidence of D. pneumosintes infections remain largely unknown due to unreliable surveillance or diagnostic methods.
Classification and Structure:
Kingdom: Bacteria
Phylum: Bacillota
Class: Negativicutes
Order: Selenomonadales
Family: Veillonellaceae
Genus: Dialister
Species: D. pneumosintes
Dialister pneumosintes is a nonfermentative bacterium. It is an anaerobic organism, meaning it thrives in environments without oxygen. This bacterium is classified as gram-negative. The size of cells typically ranges from 0.5 to 0.8 μm in width and 1.5 to 3.0 μm in length.
These cells are commonly arranged in pairs or short chains. They may exhibit either tapered or blunt ends. Dialister pneumosintes cells have a thin peptidoglycan layer and an outer membrane. However, they lack a capsule and flagella.
Dialister pneumosintes have the potential to produce enzymes that can degrade host tissues and disrupt the host immune system. Specifically, it may secrete proteases capable of breaking down collagen and elastin fibers within the periodontal ligament, ultimately destroying periodontal tissues.
Notably, ATCC 33048 and CCUG 21025 strains are representative examples of D. pneumosintes. These enzymatic activities can contribute to the bacterium’s pathogenicity within the oral cavity.
Dialister pneumosintes, a member of the normal oral flora in some individuals, can transition to a pathogenic state under specific conditions. Poor oral hygiene, trauma, surgical procedures, or immunosuppression can contribute to its pathogenicity. In such situations, this bacterium is capable of causing inflammation and infection of the gums and teeth.
It achieves this by producing toxins, enzymes, or biofilms that damage oral tissues or, in some cases, enable evasion of the host immune system. D. pneumosintes can enter the bloodstream through damaged oral mucosa or dental procedures.
From there, it can disseminate to other organs and tissues throughout the body, leading to potentially severe consequences such as bacteremia, sepsis, pneumonia, meningitis, or brain abscess. This ability to spread and establish infections at diverse sites underscores the gravity of D. pneumosintes-related illnesses.
Crucially, D. pneumosintes can also employ various strategies to suppress or evade the host immune system. It accomplishes this by producing a protective capsule, forming biofilms, or releasing immunomodulatory factors. These mechanisms shield the bacterium from host immune recognition or elimination, enabling its persistence and proliferation within the host.
Human host defenses against Dialister pneumosintes involve a complex interplay of various immune components, including saliva and salivary defense proteins. Saliva, produced by minor & major salivary glands, is a dynamic body fluid that influences the oral environment. It contains a diverse mixture of molecules, resulting in “mixed saliva,” which is crucial in maintaining oral health.
One significant role of saliva is in acquired pellicle formation on tooth surfaces. This thin layer of salivary proteins, with calcium hydroxide binding properties, helps maintain the balance of mineralization on teeth and acts as a defense against bacterial adhesion and colonization, which can lead to dental issues like caries and periodontal inflammation.
Saliva also contributes to the physico-chemical and immune defense of oral and upper gastrointestinal mucosal surfaces. It contains numerous defense proteins, including salivary immunoglobulins and antimicrobial peptides (host defense peptides or HDPs). These molecules are critical components of innate and acquired immunity, exerting direct antimicrobial actions and agglutinating or excluding microbes from mucosal surfaces.
The primary classes of salivary antibodies include IgA and IgM, with secretory IgA (sIgA) being a predominant form in saliva. The secretory components (SC) of a polymeric immunoglobulin receptor (pIgR) play a crucial role in the secretion of sIgA. Free SCs in saliva have innate defense functions, such as inhibiting bacterial adhesion and neutralizing bacterial toxins.
Host defense peptides, including defensins, cathelicidins, and histatins, are also in saliva. These peptides exhibit broad-spectrum antimicrobial activities and can effectively combat pathogenic microorganisms. They contribute to the innate immune reactions against microbial invasion in the oral cavity and airway.
Salivary defense proteins form a network of molecular defenses in the oral cavity. Multiple proteins can act together to create a “multi-hit” approach, enhancing the elimination of pathogens. These defense networks are responsible for microbial agglutination, lysis of microbial membranes, antifungal and antiviral properties, and immune regulation.
Dialister pneumosintes infections can manifest in various clinical scenarios:
Dental or Periodontal Infections: D. pneumosintes can lead to gingivitis or periodontitis, involving inflammation and infection of the gums and teeth. Typical symptoms encompass redness, swelling, bleeding, pain, and persistent bad breath.
Sinus Infections: This bacterium can cause sinusitis, characterized by inflammation and infection of the sinuses. Symptoms often include nasal congestion, nasal discharge, headache, facial pain, and sometimes fever.
Lung Infections: D. pneumosintes has the potential to induce pneumonia, an inflammatory and infectious condition affecting the lungs. Symptoms may encompass cough, chest pain, shortness of breath, and fever. In prolonged cases, the disease can lead to sepsis, a life-threatening condition where the pathogen spreads into the bloodstream, possibly leading to organ failure.
Brain Infections: One of the more severe consequences can be the development of brain abscesses. These are localized collections of pus within brain tissue and can manifest with symptoms like severe headaches, nausea, vomiting, confusion, seizures, and even paralysis. Timely treatment is crucial as brain abscesses can be fatal if left untreated.
Culture test: To diagnose Dialister pneumosintes, a culture test can be conducted using selective media designed explicitly for anaerobic bacteria. One such medium is CDC Anaerobe Blood Agar supplemented with hemin and menadione.
When cultured under strict anaerobic conditions, D. pneumosintes typically forms small, round, convex, and translucent colonies with a characteristic grayish color. Microscopic examination may reveal gram-negative rods, typically arranged in pairs or short chains.
Molecular Methods: Dialister pneumosintes can be detected using molecular techniques effectively. These include 16S rRNA gene sequencing, polymerase chain reaction, or fluorescence in situ
hybridization (FISH). These molecular methods offer advantages over traditional culture-based approaches as they tend to be more sensitive and specific, providing faster and more accurate results. However, it’s important to note that the availability and standardization of these methods may vary among clinical laboratories.
Dialister pneumosintes, originally isolated from the nasopharyngeal secretions of patients during the influenza epidemics of 1918 through 1921, was initially considered a potential causative agent of influenza. However, subsequent research invalidated this hypothesis.
Instead, Dialister pneumosintes is primarily associated with dental and periodontal infections, notably gingivitis and periodontitis. Its presence has been identified in a substantial proportion, up to 83%, of subgingival plaque samples from individuals with periodontal diseases. Additionally, it has been detected in dental root canal infections.
This bacterium is not confined to oral infections alone; it can also lead to sinus infections, particularly in individuals with chronic sinusitis or nasal polyps. Cases involving Dialister pneumosintes have been reported in sinus aspirates or biopsies.
On rare occasions, D. pneumosintes can trigger severe systemic infections, including pneumonia, sepsis, and brain abscesses. These systemic infections are infrequent and typically affect immunocompromised or debilitated patients.
Only a few documented cases of these infections exist in the medical literature, with a high mortality rate ranging from 25% to 100%. The prevalence and incidence of D. pneumosintes infections remain largely unknown due to unreliable surveillance or diagnostic methods.
Classification and Structure:
Kingdom: Bacteria
Phylum: Bacillota
Class: Negativicutes
Order: Selenomonadales
Family: Veillonellaceae
Genus: Dialister
Species: D. pneumosintes
Dialister pneumosintes is a nonfermentative bacterium. It is an anaerobic organism, meaning it thrives in environments without oxygen. This bacterium is classified as gram-negative. The size of cells typically ranges from 0.5 to 0.8 μm in width and 1.5 to 3.0 μm in length.
These cells are commonly arranged in pairs or short chains. They may exhibit either tapered or blunt ends. Dialister pneumosintes cells have a thin peptidoglycan layer and an outer membrane. However, they lack a capsule and flagella.
Dialister pneumosintes have the potential to produce enzymes that can degrade host tissues and disrupt the host immune system. Specifically, it may secrete proteases capable of breaking down collagen and elastin fibers within the periodontal ligament, ultimately destroying periodontal tissues.
Notably, ATCC 33048 and CCUG 21025 strains are representative examples of D. pneumosintes. These enzymatic activities can contribute to the bacterium’s pathogenicity within the oral cavity.
Dialister pneumosintes, a member of the normal oral flora in some individuals, can transition to a pathogenic state under specific conditions. Poor oral hygiene, trauma, surgical procedures, or immunosuppression can contribute to its pathogenicity. In such situations, this bacterium is capable of causing inflammation and infection of the gums and teeth.
It achieves this by producing toxins, enzymes, or biofilms that damage oral tissues or, in some cases, enable evasion of the host immune system. D. pneumosintes can enter the bloodstream through damaged oral mucosa or dental procedures.
From there, it can disseminate to other organs and tissues throughout the body, leading to potentially severe consequences such as bacteremia, sepsis, pneumonia, meningitis, or brain abscess. This ability to spread and establish infections at diverse sites underscores the gravity of D. pneumosintes-related illnesses.
Crucially, D. pneumosintes can also employ various strategies to suppress or evade the host immune system. It accomplishes this by producing a protective capsule, forming biofilms, or releasing immunomodulatory factors. These mechanisms shield the bacterium from host immune recognition or elimination, enabling its persistence and proliferation within the host.
Human host defenses against Dialister pneumosintes involve a complex interplay of various immune components, including saliva and salivary defense proteins. Saliva, produced by minor & major salivary glands, is a dynamic body fluid that influences the oral environment. It contains a diverse mixture of molecules, resulting in “mixed saliva,” which is crucial in maintaining oral health.
One significant role of saliva is in acquired pellicle formation on tooth surfaces. This thin layer of salivary proteins, with calcium hydroxide binding properties, helps maintain the balance of mineralization on teeth and acts as a defense against bacterial adhesion and colonization, which can lead to dental issues like caries and periodontal inflammation.
Saliva also contributes to the physico-chemical and immune defense of oral and upper gastrointestinal mucosal surfaces. It contains numerous defense proteins, including salivary immunoglobulins and antimicrobial peptides (host defense peptides or HDPs). These molecules are critical components of innate and acquired immunity, exerting direct antimicrobial actions and agglutinating or excluding microbes from mucosal surfaces.
The primary classes of salivary antibodies include IgA and IgM, with secretory IgA (sIgA) being a predominant form in saliva. The secretory components (SC) of a polymeric immunoglobulin receptor (pIgR) play a crucial role in the secretion of sIgA. Free SCs in saliva have innate defense functions, such as inhibiting bacterial adhesion and neutralizing bacterial toxins.
Host defense peptides, including defensins, cathelicidins, and histatins, are also in saliva. These peptides exhibit broad-spectrum antimicrobial activities and can effectively combat pathogenic microorganisms. They contribute to the innate immune reactions against microbial invasion in the oral cavity and airway.
Salivary defense proteins form a network of molecular defenses in the oral cavity. Multiple proteins can act together to create a “multi-hit” approach, enhancing the elimination of pathogens. These defense networks are responsible for microbial agglutination, lysis of microbial membranes, antifungal and antiviral properties, and immune regulation.
Dialister pneumosintes infections can manifest in various clinical scenarios:
Dental or Periodontal Infections: D. pneumosintes can lead to gingivitis or periodontitis, involving inflammation and infection of the gums and teeth. Typical symptoms encompass redness, swelling, bleeding, pain, and persistent bad breath.
Sinus Infections: This bacterium can cause sinusitis, characterized by inflammation and infection of the sinuses. Symptoms often include nasal congestion, nasal discharge, headache, facial pain, and sometimes fever.
Lung Infections: D. pneumosintes has the potential to induce pneumonia, an inflammatory and infectious condition affecting the lungs. Symptoms may encompass cough, chest pain, shortness of breath, and fever. In prolonged cases, the disease can lead to sepsis, a life-threatening condition where the pathogen spreads into the bloodstream, possibly leading to organ failure.
Brain Infections: One of the more severe consequences can be the development of brain abscesses. These are localized collections of pus within brain tissue and can manifest with symptoms like severe headaches, nausea, vomiting, confusion, seizures, and even paralysis. Timely treatment is crucial as brain abscesses can be fatal if left untreated.
Culture test: To diagnose Dialister pneumosintes, a culture test can be conducted using selective media designed explicitly for anaerobic bacteria. One such medium is CDC Anaerobe Blood Agar supplemented with hemin and menadione.
When cultured under strict anaerobic conditions, D. pneumosintes typically forms small, round, convex, and translucent colonies with a characteristic grayish color. Microscopic examination may reveal gram-negative rods, typically arranged in pairs or short chains.
Molecular Methods: Dialister pneumosintes can be detected using molecular techniques effectively. These include 16S rRNA gene sequencing, polymerase chain reaction, or fluorescence in situ
hybridization (FISH). These molecular methods offer advantages over traditional culture-based approaches as they tend to be more sensitive and specific, providing faster and more accurate results. However, it’s important to note that the availability and standardization of these methods may vary among clinical laboratories.

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
